Weekly Roundup: Chr. Hansen and Nestlé settle HMO patent dispute, Progress Biotech lands approval for algal oil in formula

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

Chr. Hansen’s Bifidobacterium, BB-12 may help soothe infants with colic that “excessively” cry or fuss. A new study found that these babies taking the... Read More

FormattedPicture

BUSINESS NEWS

This week in nutrition news, Chr. Hansen met its expectations of delivering 7% organic growth for the 2020/21 period. The growth is reflected by the company’s... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Consumers are taking health more into their own hands as shopping has migrated online in the lingering wake of COVID-19. Trust in supplement brands and on-pack claims... Read More

FormattedPicture

BUSINESS NEWS

Microbiome technology company Eagle Genomics is partnering with Earlham Institute (EI), a bioscience research institution, to provide tools required to analyze, explore... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

AAK is bringing Progress Biotech’s algae-based DHA to the infant formula market. “This partnership means we can offer infant formula manufacturers a... Read More

trans